yeah... its chillingI am genuinely disturbed when I think of all of the people "studying" and "training" in this stuff.
Yes, important to realise that this is not just a random video, but is part of Health Education England's e-learning for NHS clinicians.
I asked someone with access to this to find out if there were any other Long COVID or ME/CFS related courses; as shown by the screenshots below, there are courses on fatigue in Long COVID, the setting up of post-COVID rehabilitation clinics, a course on "persistent physical symptoms", and a course on managing ME in adolescents (by a nurse at Great Ormond Street).
Someone with good reason to take these courses really needs to review all of this content with a critical eye and ensure that HEE receives complaints where, as in the Chalder video, bogus, fraudulent or insulting claims are made.
I see the course on setting up a multidisciplinary team features a specific doctor who is now, as of September, "the NHS’s first ever National Specialty Adviser for Long Covid – a role created to help the NHS meet the new demand for ongoing care from people suffering long term physical and psychological after-effects from the virus."
Not explicitly related but also not quite unrelated...
Yes, important to realise that this is not just a random video, but is part of Health Education England's e-learning for NHS clinicians.
I asked someone with access to this to find out if there were any other Long COVID or ME/CFS related courses; as shown by the screenshots below, there are courses on fatigue in Long COVID, the setting up of post-COVID rehabilitation clinics, a course on "persistent physical symptoms", and a course on managing ME in adolescents (by a nurse at Great Ormond Street).
Someone with good reason to take these courses really needs to review all of this content with a critical eye and ensure that HEE receives complaints where, as in the Chalder video, bogus, fraudulent or insulting claims are made.
after the initial illness has subsided physical and psychological processes contribute to ongoing symptoms, distress and disability.
Yes, i know people dont like malaise & i agree to a point because of the connotations with swooning victorian ladies.
Idea. An approach based on an idea.We have developed an approach which is based on the idea that after the initial illness has subsided physical and psychological processes contribute to ongoing symptoms, distress and disability. By targeting these processes and regulating sleep, rest and activity, as well as reducing distress it is possible that symptoms will reduce and quality of life will improve. This workshop will emphasise the importance of a formulation driven approach."
So, not person-centred, personalised medicine that is impossible to study then?This workshop will emphasise the importance of a formulation driven approach."
That has been tested and has consistently failed to deliver any real explanatory or therapeutic power.Idea. An approach based on an idea.
I absolutely detest that word "distress".
Does anyone with a broken leg, appendicitis or flu ever get described as "distressed"?
The Journal of Rheumatology's Editor-in-Chief Earl Silverman discusses this month's selection of articles that are most relevant to the clinical rheumatologist. Included is an excerpt from this month’s Editor’s Picks spotlight interview with authors Yasaman Emad, Nicola Dalbeth, John Weinman, Trudie Chalder and Keith J. Petrie about their article "Why Do Patients With Gout Not Take Allopurinol?" -doi.org/10.3899/jrheum.210950
https://www.jrheum.org/content/49/6/622Abstract
Objective. The objectives of this study were to examine the reasons patients give for nonadherence to allopurinol and to examine differences in intentional nonadherence for patients who did and did not achieve serum urate (SU) levels at treatment target.
Methods. Sixty-nine men with gout attending rheumatology clinics, all prescribed allopurinol for ≥ 6 months, completed the Intentional Non-Adherence Scale (INAS). Differences in the types of intentional nonadherence were analyzed between those who did and did not achieve SU at treatment target (< 0.36 mmol/L, 6 mg/dL).
Results. The most frequently endorsed reasons for not taking their urate-lowering therapies (ULT) were because participants wanted to lead a normal life (23%) or think of themselves as a healthy person again (20%). Patients also reported not taking allopurinol as a way of testing if they really needed it (22%). Participants with SU above target endorsed significantly more INAS items as reasons for not taking their medication, had more medicine-related concerns, and were more likely to give Testing treatment as a reason for nonadherence. Participants who were younger, single, and non–New Zealand European also endorsed more reasons for not taking their allopurinol.
Conclusion. The major reasons behind the patient’s decision not to take allopurinol relate to the desire to lead a normal life and the strategy of testing the treatment to see if they could reduce the dose without getting symptoms. These results provide some potentially modifiable targets for adherence interventions and some recommendations to clinicians about how to reframe ULT for patients in order to improve adherence.
Sixty-nine men with gout attending rheumatology clinics, ...
on't know if gout affects men more than women
podcast interview
Why Do Patients With Gout Not Take Allopurinol?
https://www.jrheum.org/content/49/6/622
(haven't listened to it; curious about TCs involvement)
"These results provide some potentially modifiable targets for adherence interventions and some recommendations to clinicians about how to reframe ULT for patients in order to improve adherence."